Alert on Falsified Drug Series: AATC
According to information received from F. Hoffmann-La Roche, there is a report of a falsified series of the drug Tezentric (atezolizumab), concentrated solution for injection, 60 mg/ml, in a 20 ml glass vial, series N H0044B01. The company has identified significant differences in the packaging and labeling compared to the original product, also noting that the Tezentric drug with series number H0044B01 (labeled as N B0044 on the vial) has never been produced by the company.
The Ministry of Health and Labor Inspection of the Republic of Armenia has stated: “There are no data on the Tezentric (atezolizumab) series N H0044B01 in the database of drugs that have passed the import examination in accordance with the prescribed legal procedure. Dear citizens, please be cautious and avoid using the drug with series N7796,” the announcement emphasizes.
Նմանատիպ հոդվածներ
Hantavirus Spreads: Deaths Reported in Ukraine
Cases of hantavirus infection and fatalities have been reported among border guards in the Semenivka district of the Che...
Years of Stench: Residents Complain About the Activities of 'Healthy Mushroom' LLC
Residents of the summer cottage area in Nurnus, Kotayk Province, are expressing their dissatisfaction with the polluted...
Dog Missing for 12 Years Reunited with Owner
A thirteen-year-old husky named Sierra has been reunited with her owner after more than ten years apart, thanks to a mic...
WHO Provides Information on Symptoms and Risks of New Virus ‘Hantavirus’
The Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, has announced that hantavirus is not...